I think it is a really difficult one. They were not in a good position before the outbreak happened and couldn't provide guidance, but the do have recurring revenue that is locked in, and have no real debt. I think at these levels they are reasonable value, although I personally want to see how the markets respond before investing right now.
Ann: Gentrack Suspends Full Year FY20 Guidance, page-4
Add GTK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.39 |
Change
0.040(0.43%) |
Mkt cap ! $971.7M | |||
| Open | High | Low | Value | Volume |
| $9.24 | $9.44 | $9.24 | $2.235M | 238.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 800 | $9.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.39 | 2730 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| GTK (ASX) Chart |